Market Landscaping and Sizing

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

A multi-billion dollar life science company needed pre diligence on a potential acquisition target